AOD-9604 research peptide
A 16-residue peptide made of a tyrosine plus residues 177 to 191 of human growth hormone, studied in rodents as a lipolytic fragment of the hormone.
Sizes, prices and availability
| Size | SKU | Stated purity | Batch COA | Price | Availability | |
|---|---|---|---|---|---|---|
| 5 mg | 5AD | Not yet provided | Not yet provided | $30.99 | Out of stock | |
| 10 mg | PP-AOD9604-10MG | Not yet provided | Not yet provided | $50.99 | In stock |
Prices and stock are checked at build time and refreshed live in your browser. Orders are US only for a flat $24.95 shipping fee. Shipping details
About AOD-9604
AOD-9604 is a synthetic peptide built from the C-terminal region of human growth hormone (hGH). Its sequence, Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, is hGH residues 177 to 191 with a tyrosine added at the N-terminus, and the two cysteines form a disulfide bond.
Ng et al. (2000) describe it as a synthetic analogue of the lipolytic domain of hGH and report, in obese Zucker rats, reduced body-weight gain, increased lipolytic activity in adipose tissue and, unlike chronic treatment with intact hGH, no adverse effect on insulin sensitivity in a clamp study. Heffernan et al. (2001) report that hGH and AOD-9604 reduced body weight and body fat in obese mice, increased beta-3-adrenergic receptor RNA expression, and failed to change body weight or lipolysis in beta-3-receptor knock-out mice, which led them to conclude that the lipolytic actions are not mediated directly through that receptor.
What the published literature covers
- Ng et al. (2000) report metabolic studies of AOD-9604 in obese Zucker rats.
- Heffernan et al. (2001) compare hGH and AOD-9604 on lipid metabolism in obese mice and beta-3-adrenergic receptor knock-out mice.
- Wilding (2004), a drug-pipeline profile, records that phase IIa trials of AOD-9604 for obesity were under way by February 2002.
Vial arithmetic
The peptide reconstitution calculator converts a vial size, diluent volume and target amount into concentration, syringe units and draws per vial. Volumes convert to syringe units with the syringe units converter. It does arithmetic only and does not suggest any amount.
FAQ
What is AOD-9604?
A 16-residue synthetic peptide: a tyrosine followed by residues 177 to 191 of human growth hormone, with a disulfide bond between the two cysteines. PubChem lists it as C78H123N23O23S2, 1815.1 g/mol.
What does the literature on AOD-9604 consist of?
Mostly rodent studies from around 2000: Ng et al. (2000) in obese Zucker rats and Heffernan et al. (2001) in obese mice. A 2004 pipeline note records phase IIa trials under way by February 2002.
How can the identity of a batch be checked?
By mass spectrometry. The monoisotopic mass of the oxidised (disulfide) form is 1813.86 Da, so [M+H]+ is expected near m/z 1814.87 and [M+2H]2+ near 907.94. A reduced, open-chain form would be about 2 Da heavier.
What sizes of AOD-9604 does Covalume list?
Covalume lists AOD-9604 in 2 sizes: 5 mg, 10 mg. Each size shows its price and live stock status in the variants table on this page.
How is the purity of AOD-9604 documented?
Each listing shows the purity the supplier states, labelled (supplier), and the batch Certificate of Analysis field reads "Not yet provided" until a batch-specific document is on file. Our guide to reading a Certificate of Analysis explains what HPLC and mass-spectrometry results show.
References
- Ng FM, Sun J, Sharma L, et al. (2000). Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Horm Res 53:274-8. PubMed 11146367 · DOI
- Heffernan M, Summers RJ, Thorburn A, et al. (2001). The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology 142:5182-9. PubMed 11713213 · DOI
- Wilding J (2004). AOD-9604 Metabolic. Curr Opin Investig Drugs 5:436-40. PubMed 15134286
Identity values are from PubChem (CID 71300630) and the cited papers; for linear peptides the mass was also checked against the sequence. Last updated 2026-11-18.
Related research peptides
- Tesamorelin Growth-hormone-releasing factor (GHRH) analogue
- Sermorelin GHRH(1-29) amide analogue
- Ipamorelin Pentapeptide growth hormone secretagogue
- CJC-1295 Long-acting GHRH analogue
- All metabolic biology peptides
From the research library
- Check the mass spectrometry on a COA yourself
- Peptide degradation pathways
- Peptide reconstitution: concentration and volume math
- Peptide purity vs peptide content: a vial mass balance
- How to read a COA HPLC chromatogram
- HPLC vs LC-MS for peptides: identity and purity workflow
- How to read an LC-MS trace: a worked peptide example
- TFA to acetate: peptide counter-ion exchange
- Peptide net charge, pI and solubility by pH
- Peptide adsorption to vials and plastics
- How long do peptides last? Stability evidence explained
- Bacteriostatic water vs sterile water